Evidence map›Paper›PMID 33561034›Full record

ReviewInternational journal of molecular sciences2020

Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice.

Mélanie Gaubert, Thomas Bardin, Alain Cohen-Solal, François Diévart, Jean-Pierre Fauvel, Régis Guieu, Stéphane Sadrin, Jean Michel Maixent, Michel Galinier, Franck Paganelli

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Mélanie GaubertDepartment of Cardiology, Aix-Marseille University, Hôpital Nord, 13015 Marseille, France.
Thomas BardinDepartment of Rheumatology, Lariboisière Hospital, 75010 Paris, France.
Alain Cohen-SolalDepartment of Cardiology, Lariboisière Hospital, 75010 Paris, France.
François DiévartDepartment of Cardiology, Villette Private Hospital, 59240 Dunkerque, France.
Jean-Pierre FauvelDepartment of Nephrology-Hypertension, Hospices Civils de Lyon, 69002 Lyon, France.
Régis GuieuCenter for CardioVascular and Nutrition Research (C2VN), INSERM, INRA and Aix-Marseille University, 13005 Marseille, France.ORCID 0000-0002-3824-0814
Stéphane SadrinUnité de recherche Clinique Pierre Deniker (URC C.S. 10587) Centre Hospitalier Henri Laborit, Université de Poitiers, 86021Poitiers, France.
Jean Michel MaixentUnité de recherche Clinique Pierre Deniker (URC C.S. 10587) Centre Hospitalier Henri Laborit, Université de Poitiers, 86021Poitiers, France.
Michel GalinierDepartment of Cardiology, Rangueil Hospital, 31059 Toulouse, France.ORCID 0000-0003-1735-3390
Franck PaganelliDepartment of Cardiology, Aix-Marseille University, Hôpital Nord, 13015 Marseille, France.
Aix-Marseille Université · FRHôpital Lariboisière · FRHôpital Rangueil · FRHospices Civils de Lyon · FRInserm · FRUniversité de Poitiers · FRUniversité de Toulon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the publication of the Framingham Heart Study, which suggested that uric acid should no longer be associated with coronary heart disease after additional adjustment for cardiovascular disease risk factors, the number of publications challenging this statement has dramatically increased. The aim of this paper was to review and discuss the most recent studies addressing the possible relation between sustained elevated serum uric acid levels and the onset or worsening of cardiovascular and renal diseases. Original studies involving American teenagers clearly showed that serum uric acid levels were directly correlated with systolic and diastolic pressures, which has been confirmed in adult cohorts revealing a 2.21-fold increased risk of hypertension. Several studies involving patients with coronary artery disease support a role for serum uric acid level as a marker and/or predictor for future cardiovascular mortality and long-term adverse events in patients with coronary artery disease. Retrospective analyses have shown an inverse relationship between serum uric acid levels and renal function, and even a mild hyperuricemia has been shown to be associated with chronic kidney disease in patients with type 2 diabetes. Interventional studies, although of small size, showed that uric acid (UA)-lowering therapies induced a reduction of blood pressure in teenagers and a protective effect on renal function. Taken together, these studies support a role for high serum uric acid levels (>6 mg/dL or 60 mg/L) in hypertension-associated morbidities and should bring awareness to physicians with regards to patients with chronic hyperuricemia.

Indexed as

AnimalsCoronary Artery DiseaseDiabetes Mellitus, Type 2HumansHypertensionHyperuricemiaLongitudinal StudiesRenal Insufficiency, Chroniccardiovascular diseasehyperuricemiarenal diseaseserum uric acid

Identifiers

PMID33561034
PMCPMC7312288
OpenAlexW3033394478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.